|本期目录/Table of Contents|

[1]李国华,王化磊,张 颖,等.尼帕病毒病的流行现状与防治研究进展[J].传染病信息,2018,05:425-429.
 LI Guo-hua,WANG Hua-lei,ZHANG Ying,et al.Current epidemiology and progress in prevention-treatment of Nipah virus disease[J].Infectious Disease Information,2018,05:425-429.
点击复制

尼帕病毒病的流行现状与防治研究进展(PDF)

《传染病信息》[ISSN:1007-8134/CN:11-3886/R]

期数:
2018年05期
页码:
425-429
栏目:
导向与述评
出版日期:
2018-10-30

文章信息/Info

Title:
Current epidemiology and progress in prevention-treatment of Nipah virus disease
作者:
李国华王化磊张 颖冯 娜杨松涛夏咸柱
832003,石河子大学动物科技学院(李国华); 130122 长春,军事科学院军事医学研究院军事兽医研究所病毒学 研究室 吉林省人兽共患病预防与控制重点实验室(李国华、王化磊、 冯娜、杨松涛、夏咸柱); 130118 长春,吉林农业大学动物科学 技术学院(张颖)
Author(s):
LI Guo-hua WANG Hua-lei ZHANG Ying FENG Na* YANG Song-tao* XIA Xian-zhu
College of Animal Science and Technology, Shihezi University, 832003, China
关键词:
尼帕病毒尼帕病毒病流行病学疫苗抗体
Keywords:
 Nipah virus Nipah virus disease epidemiology vaccine antibody
分类号:
 R373.9
DOI:
10.3969/j.issn.1007-8134.2018.05.005
文献标识码:
A
摘要:
尼帕病毒病(Nipah virus disease, NVD)是一种急性接触性、高致死性人兽共患传染病。临床症状主要表 现为发热、头痛、脑炎及咳嗽等。1998 年在马来西亚和新加坡先后出现,1999 年分离并确诊其病原为尼帕病毒。之后该 病在印度、孟加拉国多次暴发。2018 年5 月,印度再次暴发NVD 疫情,给人们造成了极大恐慌。本文以该病的流行情 况和防治研究进展为重点,从病原学、流行病学、临床症状、病理变化、实验室诊断及防治等方面介绍其研究进展。 
Abstract:
Corresponding author. YANG Song-tao, E-mail: yst62041@163.com; FENG Na, E-mail: fengna0308@126.com   [Abstract] Nipah virus disease is an acute, fatal and contagious zoonosis. Clinical manifestations include the fever, headache, Nipah virus in 1999. Afterwards, Nipah virus disease continuously outbreaks in Bangladesh and India. And the third outbreak occurs in India in May, 2018, which causes great panic. This study focuses on current epidemiology and progress in prevention-treatment of Nipah virus disease, and intrduced the research progress from the etiology, epidemiology, clinical symptoms, pathological change, laboratory diagnosis, prevention and treatment.  

参考文献/References


[1] Chua KB, Bellini WJ, Rota PA, et al. Nipah virus: a recentlyemergent deadly paramyxovirus[J]. Science, 2000,288(5470):1432-1435.
[2] Wang LF, Michalski WP, Yu M, et al. A novel P/V/C gene in anew member of the Paramyxoviridae family, which causes lethalinfection in humans, horses, and other animals[J]. J Virol, 1998,72(2):1482-1490.
[3] Nipah virus infection[EB/OL]. [2018-08-24]. https://en.wikipedia.org/wiki/Nipah_virus_infection.
[4] Harcourt BH, Tamin A, Ksiazek TG, et al. Molecularcharacterization of Nipah virus, a newly emergent paramyxovirus [J]. Virology, 2000, 271(2):334-349.
[5] Ang BSP, Lim TCC, Wang L. Nipah virus infection[J]. J ClinMicrobiol, 2018, 56(6):pii:e01875-17.
[6] Paton NI, Leo YS, Zaki SR, et al. Outbreak of Nipah-virusinfection among abattoir workers in Singapore[J]. Lancet, 1999,354(9186):1253-1256.
[7] Henipavirus outbreaks and pteropus distribution map[EB/OL]. (2014-03-17)[2018-08-24]. https:// www.cdc.gov/vhf/hendra/outbreaks/distribution-map.html.
[8] Islam MS, Sazzad HM, Satter SM, et al. Nipah virus transmissionfrom bats to humans associated with drinking traditional liquormade from date palm sap, Bangladesh, 2011-2014[J]. EmergInfect Dis, 2016, 22(4):664-670.
[9] Clayton BA. Nipah virus: transmission of a zoonotic paramyxovirus [J]. Curr Opin Virol, 2017, 22:97-104.
[10] Gurley ES, Montgomery JM, Hossain MJ, et al. Person-to-persontransmission of Nipah virus in a Bangladeshi community[J].Emerg Infect Dis, 2007, 13(7):1031-1037.
[11] Luby SP, Gurley ES. Epidemiology of henipavirus disease inhumans[J]. Curr Top Microbiol Immunol, 2012, 359:25-40.
[12] Chadha MS, Comer JA, Lowe L, et al. Nipah virus-associatedencephalitis outbreak, Siliguri, India[J]. Emerg Infect Dis,2006,12(2):235-240.
[13] Luby SP, Hossain MJ, Gurley ES, et al. Recurrent zoonotictransmission of Nipah virus into humans, Bangladesh, 2001-2007 [J]. Emerg Infect Dis, 2009, 15(8):1229-1235.
[14] Chua KB, Lam SK, Goh KJ, et al. The presence of Nipah virus inrespiratory secretions and urine of patients during an outbreak of Nipahvirus encephalitis in Malaysia[J]. J Infect, 2001, 42(1):40-43.
[15] Bonaparte MI, Dimitrov AS, Bossart KN, et al. Ephrin-B2 ligand isa functional receptor for Hendra virus and Nipah virus[J]. ProcNatl Acad Sci U S A, 2005, 102(30):10652-10657.
[16] Negrete OA, Wolf MC, Aguilar HC, et al. Two key residues inephrinB3 are critical for its use as an alternative receptor for Nipahvirus[J]. PLoS pathog, 2006, 2(2):e7.
[17] Mire CE, Satterfield BA, Geisbert JB, et al. Pathogenic differencesbetween Nipah virus Bangladesh and Malaysia strains in primates:implications for antibody therapy[J]. Sci Rep, 2016, 6:30916.
[18] Harcourt BH, Lowe L, Tamin A, et al. Genetic characterizationof Nipah virus, Bangladesh, 2004[J]. Emerg Infect Dis, 2005,11(10):1594-1597.
[19] Chua KB, Goh KJ, Wong KT, et al. Fatal encephalitis due toNipah virus among pig-farmers in Malaysia[J]. Lancet, 1999,354(9186):1257-1259.
[20] Goh KJ, Tan CT, Chew NK, et al. Clinical features of Nipah virusencephalitis among pig farmers in Malaysia[J]. N Engl J Med,2000, 342(17):1229-1235.
[21] Liu Q, Stone JA, Bradel-Tretheway B, et al. Unraveling a threestepspatiotemporal mechanism of triggering of receptor-inducedNipah virus fusion and cell entry[J]. PLoS pathog, 2013,9(11):e1003770.
[22] Bharaj P, Wang YE, Dawes BE, et al. The matrix protein of Nipahvirus targets the E3-ubiquitin ligase TRIM6 to inhibit the IKKεkinase-mediated type-I IFN antiviral response[J]. PLoS pathog,2016, 12(9):e1005880.
[23] Daniels P, Ksiazek T, Eaton BT. Laboratory diagnosis of Nipah andHendra virus infections [J]. Microbes Infect, 2001, 3(4):289-295.
[24] Middleton D, Pallister J, Klein R, et al. Hendra virus vaccine, aone health approach to protecting horse, human, and environmentalhealth[J]. Emerg Infect Dis, 2014, 20(3):372-379.
[25] Geisbert TW, Mire CE, Geisbert JB, et al. Therapeutic treatmentof Nipah virus infection in nonhuman primates with a neutralizinghuman monoclonal antibody[J]. Sci Transl Med, 2014,6(242):242ra82.
[26] Mire CE, Versteeg KM, Cross RW, et al. Single injectionrecombinant vesicular stomatitis virus vaccines protect ferretsagainst lethal Nipah virus disease[J]. Virol J, 2013, 10:353.
[27] Lo MK, Bird BH, Chattopadhyay A, et al. Single-dose replicationdefectiveVSV-based Nipah virus vaccines provide protection fromlethal challenge in Syrian hamsters[J]. Antiviral Res, 2014,101:26-29.
[28] Prescott J, DeBuysscher BL, Feldmann F, et al. Single-dose liveattenuatedvesicular stomatitis virus-based vaccine protectsAfrican green monkeys from Nipah virus disease[J]. Vaccine,2015, 33(24):2823-2839.
[29] Satterfield BA, Dawes BE, Milligan GN. Status of vaccine researchand development of vaccines for Nipah virus[J]. Vaccine, 2016,34(26):2971-2975.
[30] Bossart KN, Rockx B, Feldmann F, et al. A Hendra virus Gglycoprotein subunit vaccine protects African green monkeys fromNipah virus challenge[J]. Sci Transl Med, 2012, 4(146):146ra07.
[31] Nahar N, Mondal UK, Sultana R, et al. Piloting the use ofindigenous methods to prevent Nipah virus infection by interruptingbats' access to date palm sap in Bangladesh[J]. Health PromotInt, 2013, 28(3):378-386.

备注/Memo

备注/Memo:
[ 基金项目] 十三五重大研发专项(2017YFD0501700)
[ 作者单位] 832003,石河子大学动物科技学院(李国华); 130122 长春,军事科学院军事医学研究院军事兽医研究所病毒学 研究室 吉林省人兽共患病预防与控制重点实验室(李国华、王化磊、 冯娜、杨松涛、夏咸柱); 130118 长春,吉林农业大学动物科学 技术学院(张颖)
[ 通信作者] 杨松涛,E-mail: yst62041@163.com;冯娜,E-mail: fengna0308@126.com
更新日期/Last Update: 2018-10-30